ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 151 filers reported holding ANIKA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $234,000 | -6.8% | 4,779 | -8.9% | 0.00% | 0.0% |
| Q3 2016 | $251,000 | -13.7% | 5,244 | -3.4% | 0.00% | 0.0% |
| Q2 2016 | $291,000 | +22.8% | 5,430 | +2.7% | 0.00% | 0.0% |
| Q1 2016 | $237,000 | -86.0% | 5,289 | -90.1% | 0.00% | -80.0% |
| Q3 2015 | $1,693,000 | -2.7% | 53,201 | +1.0% | 0.01% | +25.0% |
| Q2 2015 | $1,740,000 | +7.7% | 52,662 | +34.2% | 0.00% | 0.0% |
| Q1 2015 | $1,615,000 | +27.2% | 39,251 | +25.9% | 0.00% | +33.3% |
| Q4 2014 | $1,270,000 | +4.2% | 31,182 | -6.2% | 0.00% | 0.0% |
| Q3 2014 | $1,219,000 | -35.0% | 33,239 | -17.9% | 0.00% | -40.0% |
| Q2 2014 | $1,874,000 | +0.1% | 40,462 | -11.2% | 0.01% | 0.0% |
| Q1 2014 | $1,872,000 | -19.0% | 45,545 | -24.8% | 0.01% | -28.6% |
| Q4 2013 | $2,310,000 | – | 60,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |